Buenos Aires - Delayed Quote ARS

Johnson & Johnson (JNJ.BA)

10,581.00 +101.00 (+0.96%)
At close: April 25 at 4:56 PM GMT-3
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
85,159,000.00
85,159,000.00
79,990,000.00
78,740,000.00
82,584,000.00
Cost of Revenue
26,553,000.00
26,553,000.00
24,596,000.00
23,402,000.00
28,427,000.00
Gross Profit
58,606,000.00
58,606,000.00
55,394,000.00
55,338,000.00
54,157,000.00
Operating Expense
36,597,000.00
36,597,000.00
34,381,000.00
34,395,000.00
34,424,000.00
Operating Income
22,009,000.00
22,009,000.00
21,013,000.00
20,943,000.00
19,733,000.00
Net Non Operating Interest Income Expense
489,000.00
489,000.00
214,000.00
-130,000.00
-90,000.00
Other Income Expense
-7,436,000.00
-7,402,000.00
-1,858,000.00
-1,635,000.00
-3,146,000.00
Pretax Income
15,062,000.00
15,062,000.00
19,359,000.00
19,178,000.00
16,497,000.00
Tax Provision
1,736,000.00
1,736,000.00
2,989,000.00
1,377,000.00
1,783,000.00
Net Income Common Stockholders
35,153,000.00
35,153,000.00
17,941,000.00
20,878,000.00
14,714,000.00
Diluted NI Available to Com Stockholders
35,153,000.00
35,153,000.00
17,941,000.00
20,878,000.00
14,714,000.00
Basic EPS
2.78
--
1.37
1.59
1.12
Diluted EPS
2.74
--
1.35
1.56
1.10
Basic Average Shares
12,667,500.00
--
13,126,000.00
13,160,500.00
13,162,560.00
Diluted Average Shares
12,802,000.00
--
13,319,500.00
13,370,000.00
13,353,500.00
Total Expenses
63,150,000.00
63,150,000.00
58,977,000.00
57,797,000.00
62,851,000.00
Net Income from Continuing & Discontinued Operation
35,153,000.00
35,153,000.00
17,941,000.00
20,878,000.00
14,714,000.00
Normalized Income
14,035,770.00
21,292,770.00
19,380,068.00
18,830,152.00
14,934,324.00
Interest Income
1,261,000.00
1,261,000.00
490,000.00
53,000.00
111,000.00
Interest Expense
772,000.00
772,000.00
276,000.00
183,000.00
201,000.00
Net Interest Income
489,000.00
489,000.00
214,000.00
-130,000.00
-90,000.00
EBIT
22,009,000.00
15,834,000.00
19,635,000.00
19,361,000.00
16,698,000.00
EBITDA
22,009,000.00
23,320,000.00
26,605,000.00
26,751,000.00
23,929,000.00
Reconciled Cost of Revenue
26,553,000.00
26,553,000.00
24,596,000.00
23,402,000.00
28,427,000.00
Reconciled Depreciation
7,486,000.00
7,486,000.00
6,970,000.00
7,390,000.00
7,231,000.00
Net Income from Continuing Operation Net Minority Interest
13,326,000.00
13,326,000.00
16,370,000.00
17,801,000.00
14,714,000.00
Total Unusual Items Excluding Goodwill
-802,000.00
-9,002,000.00
-3,558,000.00
-1,109,000.00
-247,000.00
Total Unusual Items
-802,000.00
-9,002,000.00
-3,558,000.00
-1,109,000.00
-247,000.00
Normalized EBITDA
22,811,000.00
32,322,000.00
30,163,000.00
27,860,000.00
24,176,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-92,230.00
-1,035,230.00
-547,932.00
-79,848.00
-26,676.00
12/31/2020 - 1/7/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers